Earnings summaries and quarterly performance for NEVRO CORP.
Research analysts who have asked questions during NEVRO CORP earnings calls.
Brandon Vazquez
William Blair & Company, L.L.C.
2 questions for NVRO
David Rescott
Baird
2 questions for NVRO
Nathan Treybeck
Wells Fargo Securities
2 questions for NVRO
Shagun Singh Chadha
RBC Capital Markets
2 questions for NVRO
William Plovanic
Canaccord Genuity
2 questions for NVRO
Adam Maeder
Piper Sandler Companies
1 question for NVRO
Anthony [for Joanne Wuensch]
Citi
1 question for NVRO
Anthony Petrone
Mizuho Group
1 question for NVRO
Avi Dahan
Needham & Company, LLC
1 question for NVRO
Bill Plovanic
Canaccord Genuity
1 question for NVRO
Carolyn [on for Travis]
Bank of America
1 question for NVRO
Justin Lin
William Blair
1 question for NVRO
Matthew Taylor
Jefferies
1 question for NVRO
Richard Newitter
Truist Securities
1 question for NVRO
Robbie Marcus
JPMorgan Chase & Co.
1 question for NVRO
Robert Marcus
JPMorgan Chase & Co.
1 question for NVRO
Robin [on for Robbie Marcus]
JPMorgan
1 question for NVRO
Suraj Kalia
Oppenheimer & Co. Inc.
1 question for NVRO
Recent press releases and 8-K filings for NVRO.
- Merger Completed: On April 3, 2025, Nevro Corp completed its merger with Palmer Merger Sub, becoming a wholly owned subsidiary of Globus Medical.
- Special Shareholder Meeting: A virtual meeting on April 2, 2025 met quorum with 75.9% of voting shares; the merger proposal was approved, though the merger compensation proposal did not receive the requisite vote.
- Change in Control & Leadership: As a result of the merger, existing directors resigned and new directors from Palmer Merger Sub were appointed.
- Delisting Initiation: Nevro requested that the NYSE halt trading and initiate delisting procedures for its shares following the merger completion.
Quarterly earnings call transcripts for NEVRO CORP.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more